Cross-talk between rapid and long term effects of progesterone on vascular tissue

Journal of Steroid Biochemistry and Molecular Biology

Volumn 115, Issue 1-2, 2009, Pages 36-43

  Cutini, Pablo ^a,b   Sellés, Juana ^a   Massheimer, Virginia ^a,b  

^a UNIVERSIDAD NACIONAL DEL SUR   (Argentina)

^b Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

Author keywords

Cell migration; Cell proliferation; Endothelial cell; Nitric oxide; Progesterone; Protein kinase C

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CHELERYTHRINE; CYCLOHEXIMIDE; DACTINOMYCIN; MITOGEN ACTIVATED PROTEIN KINASE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PHOSPHATASE; PHOSPHOTRANSFERASE; PROGESTERONE; PROTEIN KINASE C;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA STRIP; ARTICLE; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; NONHUMAN; RAT; SIGNAL TRANSDUCTION; VASCULAR TISSUE;

ANIMALS; AORTA; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; MAP KINASE SIGNALING SYSTEM; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROGESTERONE; PROTEIN KINASE C; RATS; SIGNAL TRANSDUCTION;

RATTUS;

EID: 67349229868     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2009.02.014     Document Type: Article

References (47)

1. Beato M. Gene regulation by steroid hormones. Cell 56 (1989) 335-344
2. Cordoba M., and Beconi T. Progesterone effect mediated by the voltage dependent calcium channel and protein kinase C on non-capacitated cryopreserved bovine spermatozoa. Andrologia 33 (2001) 105-112
3. Harrison D.A., Carr D.W., and Meizel S. Involvement of protein kinase A and A kinase anchoring protein in the progesterone initiated human sperm acrosome reaction. Biol. Reprod. 62 (2000) 811-820
4. Lösel R.M., Falkenstein E., Feuring M., Schultz A., Tillmann H.C., Rossol-Haseroth K., and Wehling M. Nongenomic steroid action: controversies, questions, and answers. Physiol. Rev. 83 (2003) 965-1016
5. Verikouki C.H., Hatzoglou C.H., Gourgoulianis K.I., Molyvdas P.A., Kallitsaris A., and Messinis I.E. Rapid effect of progesterone on transepithelial resistance of human fetal membranes: evidence for non-genomic action. Clin. Exp. Pharmacol. Physiol. 35 (2008) 174-179
6. Koulen P., Madry C., Duncan R.S., Hwang J.Y., Nixon E., McClung N., Gregg E.V., and Singh M. Progesterone potentiates IP(3)-mediated calcium signaling through Akt/PKB. Cell. Physiol. Biochem. 21 (2008) 161-172
7. Mendelsohn M., and Karas R. The protective effects of estrogen on the cardiovascular system. N. Engl. J. Med. 340 (1999) 1801-1811
8. Ouyang P., Michos E.D., and Karas R.H. Hormone replacement therapy and the cardiovascular system. J. Am. Coll. Cardiol. 47 (2006) 1741-1753
9. Vazquez F., Rodriguez-Manzaneque J.C., Lidon J., Edwards D., O'Malley B., and Iruela-Arispe M.L. Progesterone regulates proliferation of endothelial cells. J. Biol. Chem. 274 (1999) 2185-2192
10. Jiang C.W., Sarrel P.M., Lindsay D.C., Pool-Wilson P.A., and Collins P. Progesterone induces endothelium-independent relaxation of rabbit coronary artery in vitro. Eur. J. Pharmacol. 211 (1992) 163-167
11. Glusa E., Graser T., Wagner S., and Oettel M. Mechanisms of relaxation of rat aorta in response to progesterone and synthetic progestins. Maturitas 28 (1997) 181-191
12. Otsuki M., Saito S., Sumitani S., Kouhara T., and Kasayama S. Progesterone, but not medroxyprogesterone, inhibits vascular cell adhesion molecule-1 expression in human vascular endothelial cells. Arterioscler. Thromb. Vasc. Biol. 21 (2001) 243-248
13. Simoncini T., Mannella P., Fornari L., Caruso A., Willis M.Y., Garibaldi S., Baldacci C., and Genazzani A.R. Differential signal transduction of progesterone and medroxyprogesterone acetate in human endothelial cells. Endocrinology 145 (2004) 5745-5756
14. Braunwald E. Shattuck lecture: cardiovascular medicine at the turn of the millennium triumphs, concerns, and opportunities. N. Engl. J. Med. 337 (1997) 1360-1369
15. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362 (1993) 801-809
16. Ross R. Atherosclerosis, an inflammatory disease. N. Engl. J. Med. 340 (1999) 115-126
17. Li G., Mills I., and Sumpio B.E. Cyclic strain stimulates endothelial cell proliferation: characterization of strain requirements. Endothelium 22 (1994) 177-181
18. Sumpio B.E., and Banes A.J. Prostacyclin synthetic activity in cultured aortic endothelial cells undergoing cyclic mechanical deformation. Surgery 104 (1998) 383-389
19. Davidge S.T., Pitt B.R., McLaughlin M.K., Roberts J.M., and Johnson B.A. Biphasic stimulation of prostacyclin by endogenous nitric oxide (NO) in endothelial cells transfected with inducible NO synthase. Gen. Pharmacol. 33 (1999) 383-387
20. Palmer R.M., Ferrige A.G., and Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327 (1987) 524-526
21. Liu J., Hughes T.E., and Sessa W.C. The first 35 amino acids and fatty acylation sites determine the molecular targeting of endothelial nitric oxide synthase into the Golgi region of cells: a green fluorescent protein study. J. Cell Biol. 137 (1997) 1525-1535
22. Ignarro L.J. Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein. Circ. Res. 65 1 (1989) 1-21
23. Tsao P.S., Lewis N.P., Alpert S., and Cooke J.P. Exposure to shear stress alters endothelial adhesiveness. Role of nitric oxide. Circulation 92 (1995) 3513-3519
24. Sellés J., Polini N., Alvarez C., and Massheimer V. Progesterone and 17 beta-estradiol acutely stimulate nitric oxide synthase activity in rat aorta and inhibit platelet aggregation. Life Sci. 69 (2001) 815-827
25. Sellés J., Polini N., Alvarez C., and Massheimer V. Non genomic action of progesterone in rat aorta: role of nitric oxide and prostaglandins. Cell. Signal. 14 (2002) 431-436
26. Mendiberri J., Rauschemberger M.B., Sellés J., and Massheimer V. Involvement of phosphoinositide-3-kinase and phospholipase C transduction systems in the non-genomic action of progesterone in vascular tissue. Int. J. Biochem. Cell Biol. 38 (2006) 288-296
27. Rauschemberger M.B., Sellés J., and Massheimer V. The direct action of estrone on vascular tissue involves genomic and non-genomic actions. Life Sci. 82 (2008) 115-123
28. Yeh Y.C., Hwang G.Y., Liu I.P., and Yang V.C. Identification and expression of scavenger receptor SR-BI in endothelial cells and smooth muscle cells of rat aorta in vitro and in vivo. Atherosclerosis 161 (2002) 95-103
29. Bachetti T., and Morbidelli L. Endothelial cells in culture: a model for studying vascular functions. Pharmacol. Res. 42 (2000) 9-19
30. Griess P. Bemerkungen zu der abhandlung der H.H. Weselsky und Benedikt "Ueber einige azoverbindungen". Chem. Ber. 12 (1879) 426-434
31. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 195 (1951) 265-277
32. Massheimer V., Polini N., Alvarez C., Benozzi S., Rauschemberger M.B., and Sellés J. Signal transduction pathways involved in non-genomic action of estrone on vascular tissue. Steroids 71 (2006) 857-864
33. Kyaw M., Yoshizumi M., Tsuchiya K., Kirima K., Suzaki Y., Abe S., Hasegawa T., and Tamaki T. Antioxidants inhibit endothelin-1 (1-31)-induced proliferation of vascular smooth muscle cells via the inhibition of mitogen-activated protein (MAP) kinase and activator protein-1 (AP-1). Biochem. Pharmacol. 64 (2002) 1521-1531
34. Burk R.R. A factor from a transformed cell line that affects cell migration. Proc. Natl. Acad. Sci. USA 70 (1973) 368-372
35. Pedram, Razandi M., Aitkenhead M., Hughes C.C.W., and Levin E.R. Integration of the non-genomic and genomic actions of estrogen. J. Biol. Chem. 277 (2002) 50768-50775
36. Truss M., and Beato M. Steroid hormone receptors: interaction with deoxyribonucleic acid and transcription factors. Endocr. Rev. 14 (1993) 459-479
37. Wehling M., and Lösel R. Non-genomic steroid hormone effects: membrane or intracellular receptors?. J. Steroid Biochem. Mol. Biol. 102 (2006) 180-183
38. Lösel R., and Wehling M. Nongenomic actions of steroid hormones. Nat. Rev. Mol. Cell Biol. 4 (2003) 46-56
39. Rowan B.G., Garrison N., Weigel N.L., and O'Malley B.W. 8-Bromo-cyclic AMP induces phosphorylation of two sites in SRC-1 that facilitate ligand-independent activation of the chicken progesterone receptor and are critical for functional cooperation between SRC-1 and CREB binding protein. Mol. Cell. Biol. 20 (2000) 8720-8730
40. Chamblis K., and Shaul P. Estrogen modulation of endothelial nitric oxide synthase. Endocr. Rev. 23 (2002) 665-686
41. Paravicini T.M., and Touyz R.M. Redox signaling in hypertension. Cardiovasc. Res. 71 (2006) 247-258
42. Liszewska E., Rekawiecki R., and Kotwika J. Effect of progesterone on the expression of bax and bcl-2 and on caspase activity in bovine luteal cells. Prostaglandins Other Lipid Mediat. 78 (2005) 67-81
43. Versari D., Lerman L.O., and Lerman A. The importance of reendothelialization after arterial injury. Curr. Pharm. Des. 13 (2007) 1811-1824
44. Sarkar R., Gordon D., Stanley J.C., and Webb R.C. Cell cycle effects of nitric oxide on vascular smooth muscle cells. Am. J. Physiol. 272 (1997) H1810-H1818
45. Cui P., Yu M., Luo Z., Dai M., Han J., Xiu R., and Yang Z. Intracellular signaling pathways involved in cell growth inhibition of human umbilical vein endothelial cells by melatonin. J. Pineal Res. 44 (2008) 107-114
46. Rojas S., Rojas R., Lamperti L., Casanello P., and Sobrevia L. Hyperglycaemia inhibits thymidine incorporation and cell growth via protein kinase C, mitogen-activated protein kinases and nitric oxide in human umbilical vein endothelium. Exp. Physiol. 88 (2003) 209-219
47. Reuben D.B., Palla S.L., Hu P., Reboussin B.A., Crandall C., Herrington D.M., Barrett-Connor E., and Greendale G.A. Progestins affect mechanism of estrogen-induced C-reactive protein stimulation. Am. J. Med. 119 (2006) 167.e1-167.e8